Which hedge funds own IMUX? IMMUNIC INC, Q2 2026 13F holders
HealthcareBiotechnologyFollow
17 tracked hedge funds disclosed a position in IMUX (IMMUNIC INC) in their Q2 2026 13F filings, worth $80.4m in total. The largest holder by portfolio weight is Propel Bio Management, LLC at 2.6% of its book. 4 opened a new position this quarter: Jones Hill Capital LP, Braidwell LP, Boothbay Fund Management, LLC, Point72 Asset Management, L.P.. 8 exited: CTC Alternative Strategies, Ltd., Scientech Research LLC, Renaissance Technologies LLC.
17
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
4
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
8
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$18.6m
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$1.6m
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$80.4m
Combined value
Sum of the holders' reported positions in the security.
1.4%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.